A patient requires a dose of 99m-Technetium of 10 MBecquerel contained within 2 mL of injection. The administration is scheduled for 3 pm. The radiopharmacist needs to elute the 99m-Technetium from the generator at 9 am that morning, to allow time for the 99m-Technetium to bind to the carrier in the kit used. The volume of eluate required for the kit is 5 mL. A 10% excess of the eluate is always produced. How much 99m-Technetium is required to be eluted at 9 am? Express your answer as MBequerel and MBecquerel /mL

A patient requires a dose of 99m-Technetium of 10 MBecquerel contained within 2 mL of injection. The administration is scheduled for 3 pm. The radiopharmacist needs to elute the 99m-Technetium from the generator at 9 am that morning, to allow time for the 99m-Technetium to bind to the carrier in the kit used. The volume of eluate required for the kit is 5 mL. A 10% excess of the eluate is always produced. How much 99m-Technetium is required to be eluted at 9 am? Express your answer as MBequerel and MBecquerel /mL

Principles of Instrumental Analysis

7th Edition

ISBN:9781305577213

Author:Douglas A. Skoog, F. James Holler, Stanley R. Crouch

Publisher:Douglas A. Skoog, F. James Holler, Stanley R. Crouch

Chapter32: Radiochemical Methods

Section: Chapter Questions

Problem 32.18QAP: The streptomycin in 500 g of a broth was determined by addition of 1.25 mg of the pure antibiotic...

See similar textbooks

Similar questions

A certain drug has a half-Iife in the body of 2.5 h. What should the interval between doses be, if the concentration of drug in the body should not fall belc 40.% of its initial concentration? Round your answer to 2 significant digits.
A 25-year-old woman who was 6 months postpartum, visited her physician with complaints of tiredness, always feeling cold, muscle weakness, menorrhagia, and weight gain. Her physician noted some facial edema and dry skin. The woman's CBC indicated a mild, normocytic, normochromic anemia. See chemistry results below. Patient Reference Range Sodium 136 13-145 mEq/L Potassium 3.7 3.6-5.0 mEq/L Chloride 94 98-107 mEq/L CO2 30.0 24.0-34.0 mEq/L Glucose 90 80-12 mg/dL BUN 23 7-24 mg/dL Creatinine 0.9 0.5-1.2 mg/dL Calcium 9.7 8.5-10.5 mg/dL Cholesterol 310 <200 mg/dL Triglyceride 200 <250 mg/dL Bilirubin 0.2 0.2-1.2 mg/dL AST 40 5-40 IU/L ALP 68 30-157 IU/L CK 300 24-179 IU/L Total protein 7.3 6.0-8.4 g/dL Albumin 4.1 3.5-5.0 g/dL TSH 21.896 0.300-5.000 μIU/mL Total T4 7.33 4.60-11.0 μg/dL T3 Uptake 26 25-30% Free thyroxine index 1.91 4.5-12 Question 2 (3 points)…
Find the apparent Km and apparent Vmax for the enzyme reaction containing the inhibitor and identify the type of inhibitor The increment on the X axis is 25uM The increment on the Y axis is 8 sec uM We VISI O appvmax-0.05microM/sec; appKm=0.02microM: mixed O appvmax-0.05microM/sec; appKm=0.02microM; uncompetitive O appvmax-0.075microM/sec, appKm-0.013microM; competitive O appvmax-0.05microM/sec; appKm-0.013microM; uncompetitive O appvmax 75microM/sec; appKm-13.3microM; uncompetitive
60 50 40 kcal/mol 30 20 10 0 course of rx No activation energy is required OA. True OB. False •
what is the concentration of the unknown sample using serial diluitions: 0.05M 1.7472nm, 0.025M 0.8569nm, 0.0125M 0.4167nm, 0.00625M 0.1958nm the epsilon value is 0.0101 and l is 1 cm
You are trying to come up with a drug to inhibit the activity of an enzyme thought to have a role in liver disease. In the laboratory the enzyme was shown to have a Km of 1.0 x 10-6 M and Vmax of 0.1 micromoles/min.mg measured at room temperature. You developed an uncompetitive inhibitor. In the presence of 5.0 x 10-5 M inhibitor, the apparent Vmax was determined to be 0.02 micromoles/min.mg. What is the Ki of the inhibitor?
4
A patient is to receive 10 mEq of potassium gluconate (MW = 234) four times a day for 3 days. If the dose is to be a teaspoonful of syrup vehicle. How many grams of potassium gluconate should be used and what volume in mL should be dispensed to provide the prescribed dosage regimen?
You are studying the absorbance properties of the COVID-19 virus. You notice at (4.9500x10^-1) absorbance, the molar absorptivity of the G variant is (4.7887x10^5) M1 cm in hexane at (5.3700x10^2) nm. The concentration was determined to be (3.60x10^-4) M. What is the pathlength of the cuvette in nanometers (nm)? Please do not include units in the answer and present your answer in scientific notation. Note: Your answer is assumed to be reduced to the highest power possible. Your Answer: x10 Answer
1-arr In a study of the gas phase decomposition of phosphine at 120 °C PH3(g)- →1/4 P4(g) + 3/2 H2(g) the concentration of PH3 was followed as a function of time. It was found that a graph of In[PH3] versus time in seconds gave a straight line with a slope of -2.50×10² s1 and a y-intercept of -3.24. Based on this plot, the reaction i v O order in PH, and the half life for the reaction is seconds. zero first second
Which of the hypothetic equations below is incorrectly balanced: a. 2 X + 3 Y2Z4 → 1 X2 (Z4)3 + 6 Y2 b. 2 D2F4G + 5 G2 → 4 DG2 + 4 F2G c. 2 KLMN3 → 1 K2MN3 + 1 MN2 + 1 L2N d. 1 J12B22C11 → 12 J + 11 B2C e. 1 ABC4 → 1 AB + 2 C
The students conducted the assay for LDH activity using the two serum samples. Each cuvette (path length 1 cm) contained 3ml of a suitable assay buffer (including pyruvate as substrate). 20 microlitres of either serum was added to the cuvette and the absorbance values immediately recorded at the optimum wavelength for a period of 5 minutes (absorbance readings taken every 30 seconds). Protein concentration of serum sample (mg/ml) Change in absorbance at optimum wavelength per minute Control serum (C) 8 -0.04 Diseased serum (D) 7.8 -0.6 1c. Using the molar absorption coefficient of NADH as 6220 M-1 cm-1, and by application of the Beer-Lambert law, estimate the enzyme activity in the two samples (C and D). Express activity as moles per second. 1d. Estimate the specific activity of the two samples (moles per second per microgram).